|Articles|October 1, 1998

Clinical and Economic Considerations of Antimicrobial Use
Volume 4
Issue 11 Suppl

Optimizing Antimicrobial Therapy and Emerging Pathogens

Author(s)David P. Nicolau, PharmD

Download PDF: Optimizing Antimicrobial Therapy and Emerging Pathogens

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

Introduction

over 27 years ago

Article

Mechanisms and Current Rates of Resistance

over 27 years ago

Article

Influence of Antibiotics on the Normal Flora

over 27 years ago

Article

Therapeutic Pathways for Antimicrobial Use: General Overview

over 27 years ago

Article

Therapeutic Pathways for Antimicrobial Use: Pediatric Issues

over 27 years ago

Article

Pharmacoeconomic Impact of Appropriate Clinical Pathways

over 27 years ago

Article

Cost Savings of Clarithomycin Compared With Erythromycin or Cefaclor in the Treatment of Lower Respiratory Tract Infection: Results of a Randomized, Multicenter Study

over 27 years ago

Article

Developing Cost-Effective Guidelines for the Appropriate Use of Antimicrobial Therapy in Respiratory Tract Infection

over 27 years ago

Article

CME Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Optimizing Antimicrobial Therapy and Emerging Pathogens

Articles in this issue

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

Trending on AJMC

5 FAQs: Ebola Outbreaks and the Challenge of Public Trust

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox

How Hospital Specialty Pharmacies Are Closing the Pharmacy Desert Gap

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications

Tisagenlecleucel Yields Promising Disease-Free Survival in High-Risk Pediatric ALL: Shannon L. Maude, MD, PhD